Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer.
Pantano F, Rossi E, Iuliani M, Facchinetti A, Simonetti S, Ribelli G, Zoccoli A, Vincenzi B, Tonini G, Zamarchi R, Santini D. Pantano F, et al. Among authors: ribelli g. Sci Rep. 2020 Jan 28;10(1):1288. doi: 10.1038/s41598-020-58339-2. Sci Rep. 2020. PMID: 31992773 Free PMC article. Clinical Trial.
Emerging drugs for the treatment of bone metastasis.
Pantano F, Iuliani M, Zoccoli A, Fioramonti M, De Lisi D, Fioroni I, Ribelli G, Santoni M, Vincenzi B, Tonini G, Santini D. Pantano F, et al. Among authors: ribelli g. Expert Opin Emerg Drugs. 2015;20(4):637-51. doi: 10.1517/14728214.2015.1062876. Epub 2015 Jun 25. Expert Opin Emerg Drugs. 2015. PMID: 26113304 Review.
Determinants of bone specific metastasis in prostate cancer.
Manca P, Pantano F, Iuliani M, Ribelli G, De Lisi D, Danesi R, Del Re M, Vincenzi B, Tonini G, Santini D. Manca P, et al. Among authors: ribelli g. Crit Rev Oncol Hematol. 2017 Apr;112:59-66. doi: 10.1016/j.critrevonc.2017.02.013. Epub 2017 Feb 16. Crit Rev Oncol Hematol. 2017. PMID: 28325265 Review.
Denosumab for cancer-related bone loss.
Dell'Aquila E, Armento G, Iuliani M, Simonetti S, D'Onofrio L, Zeppola T, Madaudo C, Russano M, Citarella F, Ribelli G, Pantano F, Vincenzi B, Tonini G, Santini D. Dell'Aquila E, et al. Among authors: ribelli g. Expert Opin Biol Ther. 2020 Nov;20(11):1261-1274. doi: 10.1080/14712598.2020.1814731. Epub 2020 Sep 9. Expert Opin Biol Ther. 2020. PMID: 32835531 Review.
18 results